These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8113998)
1. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats. Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998 [TBL] [Abstract][Full Text] [Related]
2. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. Bhargava HN; Gulati A; Ramarao P J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075 [TBL] [Abstract][Full Text] [Related]
3. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA Brain Res; 1993 Jan; 600(1):151-5. PubMed ID: 8093675 [TBL] [Abstract][Full Text] [Related]
4. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist. Bhargava HN; Kumar S Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737 [TBL] [Abstract][Full Text] [Related]
5. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats. Tejwani GA; Rattan AK; Koo KL; Matwyshyn GA; Bhargava HN Pharmacology; 1994 Apr; 48(4):216-25. PubMed ID: 8177908 [TBL] [Abstract][Full Text] [Related]
6. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. Veeranna ; Reddy PL; Bhargava HN Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat. Bhargava HN; Gulati A; Rahmani NH Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157 [TBL] [Abstract][Full Text] [Related]
8. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat. Reddy VP; Bhargava HN Neuropharmacology; 1992 Dec; 31(12):1243-9. PubMed ID: 1470300 [TBL] [Abstract][Full Text] [Related]
9. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats. Bhargava HN; Gulati A; Ramarao P Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533 [TBL] [Abstract][Full Text] [Related]
10. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice. Ho BY; Takemori AE J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102 [TBL] [Abstract][Full Text] [Related]
11. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Gudehithlu KP; Tejwani GA; Bhargava HN Brain Res; 1991 Jul; 553(2):284-90. PubMed ID: 1933285 [TBL] [Abstract][Full Text] [Related]
12. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H. Ho BY; Takemori AE J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935 [TBL] [Abstract][Full Text] [Related]
13. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist. Bhargava HN; Ramarao P; Gulati A Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058 [TBL] [Abstract][Full Text] [Related]
14. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat. Bhargava HN; Matwyshyn GA; Gudehithlu KP Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice. Thorat SN; Veeranna ; Reddy PL; Bhargava HN Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957 [TBL] [Abstract][Full Text] [Related]
16. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli. Idänpään-Heikkilä JJ; Kalso EA; Seppälä T J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439 [TBL] [Abstract][Full Text] [Related]
17. The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Rattan AK; Koo KL; Tejwani GA; Bhargava HN Brain Res; 1992 Jul; 584(1-2):207-12. PubMed ID: 1355391 [TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse. Bhargava HN; Cao YJ Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726 [TBL] [Abstract][Full Text] [Related]
19. Beta-lactam antibiotic prevents tolerance to the hypothermic effect of a kappa opioid receptor agonist. Rawls SM; Robinson W; Patel S; Baron A Neuropharmacology; 2008 Oct; 55(5):865-70. PubMed ID: 18644397 [TBL] [Abstract][Full Text] [Related]
20. Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors. Bhargava HN; Ramarao P; Gulati A Prog Clin Biol Res; 1990; 328():153-6. PubMed ID: 2406759 [No Abstract] [Full Text] [Related] [Next] [New Search]